PERMIXON 160 mg, hard capsule 180 capsules
Active ingredients: SERENOA REPENS (EXTRAIT LIPIDO-STÉROLIQUE DE)
Commercialized according to BDPM
Hard capsule180 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PERMIXON 160 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 180 gélule(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 May 2013
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61743292CIP74901326CIP133400949013265Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SERENOA REPENS (EXTRAIT LIPIDO-STÉROLIQUE DE)gélule | 160 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.